1 Table of Contents
2 Introduction_x000D_
2.1 What Is This Report About?_x000D_
2.2 Glaucoma Surgery Devices Market Segmentation_x000D_
2.3 Definitions of Markets Covered in the Report_x000D_
3 Glaucoma Surgery Devices Market, North America_x000D_
3.1 Glaucoma Surgery Devices Market, North America, Revenue ($m), 2018-2033_x000D_
3.2 Glaucoma Surgery Devices Market, North America, Revenue ($m), 2018-2033_x000D_
3.3 Glaucoma Surgery Devices Market, North America, Volume (Units), 2018-2033_x000D_
3.4 Glaucoma Surgery Devices Market, North America, Volume (Units), 2018-2033_x000D_
3.5 Glaucoma Surgery Devices Market, North America, Company Share by Revenue ($m), 2024_x000D_
4 Glaucoma Surgery Devices Market, Canada_x000D_
4.1 Glaucoma Surgery Devices Market, Canada, Revenue ($m), 2018-2033_x000D_
4.1.1 Glaucoma Drainage Devices Market, Canada, Revenue ($m), by Segment, 2018-2033_x000D_
4.2 Glaucoma Surgery Devices Market, Canada, Volume (Units), 2018-2033_x000D_
4.2.1 Glaucoma Drainage Devices Market, Canada, Volume (Units), by Segment, 2018-2033_x000D_
4.3 Glaucoma Surgery Devices Market, Canada, Average Price ($), 2018-2033_x000D_
4.4 Glaucoma Surgery Devices Market, Canada, Company Share by Revenue ($m), 2024_x000D_
5 Glaucoma Surgery Devices Market, Mexico_x000D_
5.1 Glaucoma Surgery Devices Market, Mexico, Revenue ($m), 2018-2033_x000D_
5.1.1 Glaucoma Drainage Devices Market, Mexico, Revenue ($m), by Segment, 2018-2033_x000D_
5.2 Glaucoma Surgery Devices Market, Mexico, Volume (Units), 2018-2033_x000D_
5.2.1 Glaucoma Drainage Devices Market, Mexico, Volume (Units), by Segment, 2018-2033_x000D_
5.3 Glaucoma Surgery Devices Market, Mexico, Average Price ($), 2018-2033_x000D_
5.4 Glaucoma Surgery Devices Market, Mexico, Company Share by Revenue ($m), 2024_x000D_
6 Glaucoma Surgery Devices Market, United States_x000D_
6.1 Glaucoma Surgery Devices Market, United States, Revenue ($m), 2018-2033_x000D_
6.1.1 Glaucoma Drainage Devices Market, United States, Revenue ($m), by Segment, 2018-2033_x000D_
6.2 Glaucoma Surgery Devices Market, United States, Volume (Units), 2018-2033_x000D_
6.2.1 Glaucoma Drainage Devices Market, United States, Volume (Units), by Segment, 2018-2033_x000D_
6.3 Glaucoma Surgery Devices Market, United States, Average Price ($), 2018-2033_x000D_
6.4 Glaucoma Surgery Devices Market, United States, Company Share by Revenue ($m), 2024_x000D_
7 Overview of Key Companies in North America Glaucoma Surgery Devices Market_x000D_
7.1 Glaukos Corp_x000D_
7.1.1 Company Overview_x000D_
7.2 Allergan Aesthetics_x000D_
7.2.1 Company Overview_x000D_
7.3 New World Medical, Incorporated_x000D_
7.3.1 Company Overview_x000D_
7.4 Alcon Inc_x000D_
7.4.1 Company Overview_x000D_
7.5 Johnson & Johnson Vision Care Inc_x000D_
7.5.1 Company Overview_x000D_
8 Glaucoma Surgery Devices Market Pipeline Products_x000D_
9 Recent Developments_x000D_
9.1 Corporate Communications_x000D_
9.1.1 Oct 14, 2025: Smartlens, Inc. Secures $5.2 Million Bridge Round for FDA Clearance and Commercial Launch of miLens_x000D_
9.1.2 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed_x000D_
9.1.3 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio_x000D_
9.2 Financial Announcements_x000D_
9.2.1 Nov 05, 2025: Ocugen Provides Business Update with Third Quarter 2025 Financial Results_x000D_
9.2.2 Oct 08, 2025: Glaukos To Release Third Quarter 2025 Financial Results After Market Close On October_x000D_
9.2.3 Mar 03, 2025: Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2024 Results and Business Highlights_x000D_
9.2.4 Feb 11, 2025: STAAR Surgical Reports Fourth Quarter and Fiscal Year 2024 Results_x000D_
9.2.5 Jan 23, 2025: Glaukos to Release Fourth Quarter and Full Year 2024 Financial Results after Market Close on February_x000D_
9.2.6 Jan 13, 2025: STAAR Surgical to Host Fourth Quarter and Fiscal Year 2024 Earnings Conference Call and Webcast on February 19, 2025_x000D_
9.3 Government and Public Interest_x000D_
9.3.1 Nov 03, 2025: Glaukos Announces Participation in Upcoming Investor Conferences_x000D_
9.3.2 Nov 25, 2024: STAAR Surgical to Participate in BTIG Ophthalmology Day_x000D_
9.4 Other Significant Developments_x000D_
9.4.1 Nov 11, 2025: New Publications Highlight OMNI Surgical System's Effectiveness in Reducing IOP_x000D_
9.4.2 Nov 05, 2025: Ocugen Provides Business Update with Third Quarter 2025 Financial Results_x000D_
9.4.3 Oct 07, 2025: Zeiss Expands DORC Portfolio and Strengthens Digital Footprint with Improved Workflow Efficiency and Visualization_x000D_
9.5 Product News_x000D_
9.5.1 Nov 11, 2025: New Publications Highlight OMNI Surgical System's Effectiveness in Reducing IOP_x000D_
9.5.2 Nov 10, 2025: SpyGlass Pharma Reports Positive Results from BIM-IOL System Trials_x000D_
9.5.3 Nov 05, 2025: Ocugen Provides Business Update with Third Quarter 2025 Financial Results_x000D_
9.5.4 Oct 14, 2025: Smartlens, Inc. Secures $5.2 Million Bridge Round for FDA Clearance and Commercial Launch of miLens_x000D_
9.5.5 Oct 07, 2025: Zeiss Expands DORC Portfolio and Strengthens Digital Footprint with Improved Workflow Efficiency and Visualization_x000D_
9.5.6 Oct 06, 2025: Samsara Vision Announces First Pseudophakic Surgery in the PERSPECTIVE Clinical Trial_x000D_
9.5.7 Sep 16, 2025: Alcon Unveils Time and Motion Study Results Demonstrating Enhanced Efficiency for Eye Surgery with UNITY VCS_x000D_
9.5.8 Feb 19, 2025: Early Study Shows Promise for Retinal-Surgery Robot Invented at the University of Utah_x000D_
9.5.9 Nov 20, 2024: Mann Eye Institute First in Texas to Offer Revolutionary Glaucoma Treatment With Voyager DSLT_x000D_
9.6 Research And Development_x000D_
9.6.1 Feb 12, 2025: New Drug Delivery Method Promises Long-Lasting Glaucoma Relief: Study_x000D_
9.7 Strategy And Business Planning_x000D_
9.7.1 Nov 05, 2025: Ocugen Provides Business Update with Third Quarter 2025 Financial Results_x000D_
9.7.2 Oct 31, 2025: Carpenter Eye Associates Joins Metrolina Eye Associates to Expand Eye Care Access_x000D_
9.7.3 Sep 25, 2025: Glaukos Begins Construction of New Facility in Huntsville, Alabama_x000D_
10 Appendix_x000D_
10.1 Research Methodology_x000D_
10.1.1 Coverage_x000D_
10.1.2 Secondary Research_x000D_
10.1.3 Primary Research_x000D_
10.1.4 Market Modeling and Forecasting_x000D_
10.1.5 Company Share Analysis_x000D_
10.1.6 Benchmarking_x000D_
10.2 GlobalData Consulting_x000D_
10.3 Contact Us_x000D_
10.4 Disclaimer